Quest Diagnostics Announces Opioid Therapy Genetic Test

The company said it is believed to be the first clinical lab to offer testing for variants in all cytochrome P450 genes known to influence the CYP450 enzyme system, which affects the metabolism of opioids.

  • Aug 09, 2013

Quest Diagnostics on Aug. 8 announced the availability of a new, lab-developed genetic test to aid in the delivery of personalized opioid pain-relieving treatment, with the company saying it is believed to be the first clinical lab to offer testing for variants in all cytochrome P450 (CYP450) genes known to influence the CYP450 enzyme system, which affects the metabolism of opioids and other medications. With it, physicians can predict the rate of opioid drug metabolism and then adjust dosages or use other therapies, reducing the likelihood of drug toxicity, drug interactions, and other adverse outcomes, according to the company.

Millions of Americans suffer from chronic pain, and opioids are frequently used for pain management. Opioids also have high rates of drug addiction and overdose in the United States.

The company's announcement said the new test is based in part on gene variants owned by Transgenomic, Inc. through a non-exclusive licensing agreement between it and Quest Diagnostics, which developed, validated, and now offers the test service through its Nichols Institute facility in San Juan Capistrano, Calif.

"Genetic testing to personalize the use of pain-alleviating drug therapies is an exciting new clinical field with tremendous potential to promote favorable outcomes for the many millions of individuals struggling with pain," said Dr. Charles Strom, MD, Ph.D., senior medical director, Genetics, for Quest Diagnostics. "Opioids can be very effective pain-alleviating medications, but they are also powerful and potentially dangerous drugs carrying a high risk of addiction, toxicity, and other adverse effects. The inclusion of Transgenomic's gene discoveries into our genetic testing services will provide physicians with greater insights for safely and effectively administering opioid treatment."

Product Showcase

  • SECUPRO MARTEGO

    FOR HIGHEST DEMANDS. A cutting tool in which function and design go hand in hand. Meet the SECUPRO MARTEGO, our prize-winning squeeze-grip safety knife with fully automatic retractable blade for safety. • Ergonomically friendly trigger mechanism to engage the blade • Durable body made of aluminum • Safer alternative to fixed blade utility knives for general cutting tasks • 9 mm Cutting depth • Easy, tool free blade change Dimensions: L 6.10" L x 0.71" W x 1.91" H Weight: 3.70 oz Cutting Depth: 9 mm Read More

  • Safety Shower Test Cart

    The Safety Shower Test Cart speeds up and simplifies emergency shower tests, ensures you stay in compliance with OSHA regulations, and significantly reduces testing costs. With 7 unique features, the cart makes testing easy, effective, and efficient. You can test water clarity, flow, temperature, and spread—all at the same time! Most safety shower testing kits create a mess, take too much time to use, and don't fully help you stay in compliance with OSHA & ANSI standards. Transform the way you test emergency showers with Green Gobbler Safety. Read More

  • The MGC Simple Plus

    The MGC Simple Plus is a simple-to-use, portable multi gas detector that runs continuously for three years without being recharged or routinely calibrated after its initial charge and calibration during manufacturing. The detector reliably tests a worksite’s atmosphere for hydrogen sulfide, carbon monoxide, oxygen and combustible gases (LEL). Its durability enables the detector to withstand the harshest treatment and environments, hence earning it an IP 68 rating. The MGC Simple Plus is also compatible with a variety of accessories, such as the GCT External Pump. Visit gascliptech.com for more information. Read More

Featured

Most   Popular

Artificial Intelligence